Kurome Therapeutics
PrivateLast Round
Series A
Jun 10, 2021
Total Funding Raised
$19M
Company Overview
Kurome Therapeutics is a biotechnology company that develops small-molecule therapies targeting dysregulated immune signaling pathways in hematological cancers such as acute myeloid leukemia and myelodysplastic syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kurome Therapeutics Comparables
Compare Kurome Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eilean Therapeutics | 93% | |
| Arog Pharmaceuticals | 86% | |
| Hangzhou Polymed Biopharmaceuticals | 83% | |
Kurome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2021 | ||||
| Seed | Apr 29, 2020 |
Key People
Founding team and executive leadership
Kurome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QCA Ventures | Seed, Series A |
| CincyTech | Series A, Seed |
| Angel Physicians Fund | Seed |
| Medicxi | Series A |
| Affinity Asset Advisors | Series A |
Kurome Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kurome Therapeutics's valuation, stock price, and market status.